Quality Care

The Cigna subsidiary said the tools included in its formulary were reviewed by physicians, pharmacists and user experience experts.

According to a survey by the American Medical Association, 93% of physicians felt there was some advantage or a definite advantage to using digital health tools in 2022, compared with 85% in 2016.

The solution screens for plus disease, which is associated with severe ROP.

Specialty care was significantly more likely to result in concordant diagnoses between telehealth and in-person appointments, compared with primary care.

The new tool measures the diameter of the ventricles of the heart to provide the ratio of the maximum right ventricle diameter compared with the left ventricle. That can help indicate pulmonary embolism severity.

The company will maintain its patent right for the technology.

Docquity will use its fresh funds to further expand into East Asia and the Middle East.

Also, Lunit has received Taiwan's approval for its AI mammography solution.

The AI model still has a modest prediction accuracy and is slated for a wider clinical trial soon.

It will use its fresh funds to complete a multi-site validation study across eight Asia-Pacific markets.